Leuprolide Acetate 3.75 mg Injection | Lyrodrum

What is Leuprolide Acetate 3.75 mg Injection?

Leuprolide Acetate 3.75 mg Injection is a long-acting gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-dependent conditions. It works by regulating the release of sex hormones such as estrogen and testosterone, helping manage disorders caused by hormonal imbalance.

This depot formulation provides sustained drug release over one month, ensuring consistent therapeutic effects and improved patient compliance.

How Leuprolide Depot Works

Leuprolide initially stimulates the pituitary gland, followed by suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This results in a significant reduction in estrogen or testosterone levels, which helps control hormone-sensitive conditions.

Key Uses of Leuprolide Depot 3.75 mg

• Prostate cancer (advanced and hormone-dependent)

• Endometriosis

• Uterine fibroids (leiomyoma)

• Central precocious puberty

• Assisted reproductive technology (IVF protocols)

Benefits of Leuprolide Depot Injection

• Long-acting monthly formulation

• Effective hormonal suppression

• Reduces symptoms like pain and abnormal bleeding

• Improves disease control in hormone-dependent cancers

• Convenient dosing schedule

Dosage and Administration

• Strength: 3.75 mg

• Route: Intramuscular injection

• Frequency: Once every month

Why Choose Leuprolide Depot 3.75 mg?

Leuprolide Depot is a trusted therapy worldwide for managing complex hormonal conditions. Its proven efficacy, predictable hormone suppression, and convenient monthly dosing make it a preferred choice among clinicians.